Greenbrook TMS Expands Access to Breakthrough Depression Treatment in Houston Region

Coty Bishop, Roxane Zotyka, Jeannine Varela, Lexi Damon, Dr. Kimberly Cress, Kathleen Shaffer and Lizette Jackson.

Greenbrook TMS Inc., a leading provider of transcranial magnetic stimulation (TMS) therapy in the United States, announced the expansion of its TMS Center network in Katy. Greenbrook has 71 company-operated treatment centers across the U.S., including Sugar Land, and with the addition of their new location in Katy, Greenbrook is continuing to grow in the Houston region.

The new TMS Center in Katy is led by Dr. Kimberly Cress, a board-certified psychiatrist with nearly 10 years of experience treating patients with NeuroStar® Advanced Therapy, the leading TMS treatment for Major Depressive Disorder (MDD). Cress joined Greenbrook in 2018 as the Regional Medical Director in Texas and is a leader in the field of TMS and neuromodulation, having delivered more than 15,000 NeuroStar TMS treatments.

Dr. Kimberly Cress and Dr. Aqeel Hashmi.

According to Mental Health Texas, one in five area adults will experience a mental health illness in a given year. “Depression is a pressing public health priority across the country and access to treatment is critical,” said Bill Leonard, Greenbrook’s CEO and President. “We are thrilled that under Dr. Cress’ remarkable leadership Greenbrook TMS Centers are a part of improving access to much needed – and potentially life-changing – therapy to the community.”

Since receiving FDA clearance in 2008 as a safe and effective treatment for adult patients with Major Depression Disorder, NeuroStar has become a game-changer in the treatment of depression and offers hope to the 5.5 million people in the U.S. The treatment uses magnetic pulses to awaken areas of the brain that are underactive in depression. It is typically administered daily in a doctor’s office for four to six weeks. NeuroStar treatment sessions can be performed in under 19 minutes. Unlike electroconvulsive therapy (ECT), TMS therapy is non-invasive and allows patients to resume daily activities immediately following treatment sessions. It is also free from systemic side effects often associated with antidepressant medications.

“I’m thrilled to further increase patient access to this transformative treatment in the Houston region and help more people find relief from their depression and achieve the quality of life they deserve,” said Cress. “I’ve seen first-hand how effective NeuroStar TMS can be for patients who have lost hope when medications alone don’t work.”

Visit to learn more.